CLEO Diagnostics Ltd (AU:COV) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Cleo Diagnostics Ltd has announced their Annual General Meeting (AGM) for shareholders, scheduled for 10:30 am on November 27, 2024, at FB Rice’s Melbourne offices. Shareholders will review the company’s Annual Report for the fiscal year ending June 30, 2024, and vote on key resolutions, including the adoption of the Remuneration Report and the re-election of Director Adrien Wing.
For further insights into AU:COV stock, check out TipRanks’ Stock Analysis page.